skip to Main Content
Arkansas averaged $22.37M of medical marijuana per month for fiscal year

Medical marijuana finished out June for a strong fiscal year in Arkansas. For June, the final month of the budget year, medical marijuana sales generated $22.29 million in the state according to the Department of Finance and Administration.

The sales figure represents 3,296 pounds of marijuana across 38 dispensaries for the month.

The two biggest sellers for June indicate an even distribution of the market, with Sherwood’s Natural Relief Dispensary in central Arkansas selling 388 pounds for the month, and in the northwest, Bentonville’s The Releaf Center selling 313 pounds.

June marks the end of the fiscal year for sales, which show strong sales for all 12 months.

“On average, patients in Arkansas are spending $22.37 million each month to purchase 3,920 pounds of medical marijuana,” Scott Hardin, spokesperson for the Arkansas Department of Finance and Administration said. “State tax revenue generated from medical marijuana totaled $32.12 million in Fiscal Year 2022 [July 1, 2021 to June 30]. The state’s 38 dispensaries sold 23,521 pounds of medical marijuana through the first six months of 2022.”

The Department of Health reports 84,472 medical marijuana cards in the state.

[Read more at KARK]
This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

C3 Industries’ Brotherly Model for MSO Success

Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…

Why Falling THC Test Results Matter

By Aaron Pelley,  Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…

What would marijuana reclassification mean in Wisconsin?

The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…

Scientists welcome new rules on marijuana, but research will still face obstacles

As the Biden administration moves to reclassify marijuana as a less dangerous drug, scientists say the change will lift some of the restrictions on studying the drug. But the change…

More Categories

Back To Top
×Close search
Search